Authors : Jayapriya N; Abishek P; Naveena S; Srinivasan A

Volume/Issue : Volume 10 - 2025, Issue 7 - July

Google Scholar : https://tinyurl.com/4m8f53jj

Scribd : https://tinyurl.com/5x5de44b

DOI : https://doi.org/10.38124/ijisrt/25jul1963

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.

Abstract : Evans syndrome is characterized by the simultaneous or consecutive occurrence of immune thrombocytopenia, warm autoimmune hemolytic anemia, and, less frequently, autoimmune neutropenia. It is linked to non-cross-reacting autoantibodies that target antigens unique to neutrophils, platelets, or red blood cells.Corticosteroids or immunoglobulins are the first-line treatment for Evans syndrome. For patients who are not responsive to steroids, rituximab or splenectomy are the second-line treatments. Deficits of CTLA-4, LRBA, TPP2, and a reduced CD4/CD8 ratio are among the recent molecular ideas that explain the physiopathology of ES .Rituximab, mofetil mycophenolate, cyclosporine, vincristine, azathioprine, sirolimus, and thrombopoietin receptor agonists are among the second-line treatments for refractory ES. Hematopoietic stem cell transplantation has been effective in situations where immunosuppressive medications have failed to work. Since ES is chronic and has a high recurrence rate despite improvements, timely diagnosis, cautious treatment, and close patient monitoring are necessary to improve quality of life and achieve the best results. Prospective clinical trials are required for possible targeted therapy in order to improve ES.

References :

1. Palvia AR, Damera AR, Magar S, Nandi AR, Goyal M. Diagnostic and Therapeutic Strategies in Evans Syndrome: A Case Report and Literature Review. Cureus. 2024 Jul 18;16(7):e64866. doi: 10.7759/cureus.64866. PMID: 39156320; PMCID: PMC11330688.
2. Sagar Gyawali, Utsav Joshi, Zeni Kharel, Shambhu Khanal, Anjan Shrestha First published: 06 May 2021 https://doi.org/10.1002/ccr3.4113.
3. Jaime-Pérez JC, Aguilar-Calderón PE, Salazar-Cavazos L, Gómez-Almaguer D. Evans syndrome: clinical perspectives, biological insights and treatment modalities. J Blood Med. 2018 Oct 10;9:171-184. doi: 10.2147/JBM.S176144. PMID: 30349415; PMCID: PMC6190623.
4. Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin North Am. 2013 Dec;60(6):1489-511. doi: 10.1016/j.pcl.2013.08.009. Epub 2013 Oct 5. PMID: 24237984; PMCID: PMC5384653.
5. Angelopoulos A, Kirkilesis G, Kakavia K, Papanikolaou P. Diagnosis of Evans syndrome. Pan Afr Med J. 2021 Mar 29;38:314. doi: 10.11604/pamj.2021.38.314.22410. PMID: 34285737; PMCID: PMC8265255.
6. Audia S, Grienay N, Mounier M, Michel M, Bonnotte B. Evans' Syndrome: From Diagnosis to Treatment. J Clin Med. 2020 Nov 27;9(12):3851. doi: 10.3390/jcm9123851. PMID: 33260979; PMCID: PMC7759819.
7. Autore F, Pasquale R, Innocenti I, Fresa A, Sora' F, Laurenti L. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review. Cancers (Basel). 2021 Nov 19;13(22):5804. doi: 10.3390/cancers13225804. PMID: 34830959; PMCID: PMC8616265.
8. Michalak SS, Olewicz-Gawlik A, Rupa-Matysek J, Wolny-Rokicka E, Nowakowska E, Gil L. Autoimmune hemolytic anemia: current knowledge and perspectives. Immun Ageing. 2020 Nov 20;17(1):38. doi: 10.1186/s12979-020-00208-7. PMID: 33292368; PMCID: PMC7677104.
9. Lu Y, Huang XM. Autoimmune hemolytic anemia as an initial presentation in children with systemic lupus erythematosus: two case reports. J Int Med Res. 2022 Aug;50(8):3000605221115390. doi: 10.1177/03000605221115390. PMID: 35971316; PMCID: PMC9386865.
10. Loriamini M, Cserti-Gazdewich C, Branch DR. Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management. Int J Mol Sci. 2024 Apr 12;25(8):4296. doi: 10.3390/ijms25084296. PMID: 38673882; PMCID: PMC11049952.
11. Zhong K, Pei Y, Yang Z, Zheng Q. Construction of a clinical prediction model for the diagnosis of immune thrombocytopenia based on clinical laboratory parameters. J Cancer Res Clin Oncol. 2024 Sep 6;150(9):412. doi: 10.1007/s00432-024-05914-z. PMID: 39237750; PMCID: PMC11377454.
12. Al Saud AA, AlRomaizan MR, Alkhunizan MA. Thrombocytopenia following iron repletion with ferrous gluconate. Saudi Med J. 2024 Aug;45(8):848-850. doi: 10.15537/smj.2024.45.8.20231003. PMID: 39074892; PMCID: PMC11288502.
13. Jeon MJ, Yu ES, Kang KW, Lee BH, Park Y, Lee SR, Sung HJ, Yoon SY, Choi CW, Kim BS, Kim DS. Immature platelet fraction based diagnostic predictive scoring model for immune thrombocytopenia. Korean J Intern Med. 2020 Jul;35(4):970-978. doi: 10.3904/kjim.2019.093. Epub 2020 Apr 10. PMID: 32264655; PMCID: PMC7373978.
14. Neely J, von Scheven E. Autoimmune haemolytic anaemia and autoimmune thrombocytopenia in childhood-onset systemic lupus erythematosus: updates on pathogenesis and treatment. Curr Opin Rheumatol. 2018 Sep;30(5):498-505. doi: 10.1097/BOR.0000000000000523. PMID: 29979258.
15. Rivalta B, Zama D, Pancaldi G, Facchini E, Cantarini ME, Miniaci A, Prete A, Pession A. Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease. Front Pediatr. 2019 Jul 23;7:304. doi: 10.3389/fped.2019.00304. PMID: 31396497; PMCID: PMC6664023.
16. Farruggia P, Dufour C. Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians. Ther Adv Hematol. 2015 Feb;6(1):15-24. doi: 10.1177/2040620714556642. PMID: 25642312; PMCID: PMC4298488.
17. Capsoni F, Sarzi-Puttini P, Zanella A. Primary and secondary autoimmune neutropenia. Arthritis Res Ther. 2005;7(5):208-14. doi: 10.1186/ar1803. Epub 2005 Aug 31. PMID: 16207350; PMCID: PMC1257445.
18. Nielsen KR, Bojsen SR, Masmas TN, Fjordside AL, Baech J, Haunstrup TM, Steffensen R. Association between human leukocyte antigens (HLAs) and human neutrophil antigens (HNAs) and autoimmune neutropenia of infancy in Danish patients. Pediatr Allergy Immunol. 2021 May;32(4):756-761. doi: 10.1111/pai.13450. Epub 2021 Feb 9. PMID: 33421202; PMCID: PMC8248029.
19. Flesch BK, Reil A. Molecular Genetics of the Human Neutrophil Antigens. Transfus Med Hemother. 2018 Oct;45(5):300-309. doi: 10.1159/000491031. Epub 2018 Aug 17. PMID: 30498408; PMCID: PMC6257083.
20. Hansen DL, Möller S, Andersen K, Gaist D, Frederiksen H. Evans syndrome in adults - incidence, prevalence, and survival in a nationwide cohort. Am J Hematol. 2019 Oct;94(10):1081-1090. doi: 10.1002/ajh.25574. Epub 2019 Aug 9. PMID: 31292991.
21. Michel M. Adult Evans' Syndrome. Hematol Oncol Clin North Am. 2022 Apr;36(2):381-392. doi: 10.1016/j.hoc.2021.12.004. Epub 2022 Mar 11. PMID: 35282950.
22. Kim TO, Despotovic JM. Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children. Hematol Oncol Clin North Am. 2019 Jun;33(3):489-506. doi: 10.1016/j.hoc.2019.01.005. Epub 2019 Mar 23. PMID: 31030815.
23. Nixon CP, Sweeney JD. Autoimmune Cytopenias: Diagnosis & Management. R I Med J (2013). 2016 Dec 1;99(12):36-40. PMID: 27902998.
24. Michel M, Chanet V, Dechartres A, Morin AS, Piette JC, Cirasino L, Emilia G, Zaja F, Ruggeri M, Andrès E, Bierling P, Godeau B, Rodeghiero F. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood. 2009 Oct 8;114(15):3167-72. doi: 10.1182/blood-2009-04-215368. Epub 2009 Jul 28. PMID: 19638626.
25. An J, Amaruntowa P, Ahmed W, Khan A, Shahzad M. Recurrent Infection in a Young Female Patient Recently Diagnosed With Primary Evans Syndrome Without Neutropenia. J Hematol. 2024 Jun;13(3):121-124. doi: 10.14740/jh1265. Epub 2024 Jun 28. PMID: 38993737; PMCID: PMC11236364.
26. Shaikh H, Mewawalla P. Evans Syndrome. 2023 Jun 12. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30085557.
27. Stolyar L, Rizi B, Lin S, Hsieh E. Systemic lupus erythematosus presenting as Evans syndrome. Clin Case Rep. 2019 Nov 18;7(12):2513-2514. doi: 10.1002/ccr3.2550. PMID: 31893091; PMCID: PMC6935636.
28. Vaughn JE, Anwer F, Deeg HJ. Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom? Vox Sang. 2016 Jan;110(1):5-11. doi: 10.1111/vox.12314. Epub 2015 Jul 14. PMID: 26178735; PMCID: PMC4780370.
29. Raetz E, Beatty PG, Adams RH. Treatment of severe Evans syndrome with an allogeneic cord blood transplant. Bone Marrow Transplant. 1997 Sep;20(5):427-9. doi: 10.1038/sj.bmt.1700907. PMID: 9339762.
30. Mohamed KK, Al-Qurashi FO, Al-Qahtani MH, Osman YS. Early-onset Evans Syndrome in a 4-Month-Old Infant: A Case Report and Review of Literature. Saudi J Med Med Sci. 2017 May-Aug;5(2):177-180. doi: 10.4103/1658-631X.204852. Epub 2017 Apr 20. PMID: 30787781; PMCID: PMC6298364.
31. Mathew, Prasad M.D; Chen, Gang Ph.D; Wang, Winfred M.D.. Evans Syndrome: Results of a National Survey. Journal of Pediatric Hematology/Oncology 19(5):p 433-437, September 1997.
32. Savaşan S, Warrier I, Ravindranath Y. The spectrum of Evans' syndrome. Arch Dis Child. 1997 Sep;77(3):245-8. doi: 10.1136/adc.77.3.245. PMID: 9370906; PMCID: PMC1717303.
33. Nuss, Rachelle M.D.; Wang, Winfred M.D.. Intravenous Gamma Globulin for Thrombocytopenia in Children with Evans Syndrome. American Journal of Pediatric Hematology/Oncology 9(2):p 164-167, Summer 1987.